Section d6b, if explanted, give date: not applicable as the iol was not explanted.Section h3-other (81): the device was not returned for evaluation as it remains implanted.Therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.Section h-6 health effect - clinical code: 2140 photophobia and visual disturbance - dysphotopsia attempts have been made to obtain the missing information.However, to date, the information has not been received.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
It was reported the preloaded johnson and johnson (jnj) intraocular lens (iol) was implanted into the patient¿s right eye.The patient experienced an unusual inflammation centered around the iol.Their visual acuity decreased, and they experienced photopsias and photophobia.The eye was cultured and a tear organism was not seen.The patient was administered intravitreal injection of vancomycin, ceftazadime, and dexamethasone.Iol is not available for return as it remains implanted.No further information was provided.
|
Additional information was received from the customer.This supplemental is to report the new information and correct the initial submission.Additional information.The customer confirmed that the patient only had surgery in their right eye.Since two doctors were on file, the customer clarified that the operating and reporting surgeon is doctor (b)(6) feder.Customer is uncertain the role that doctor avrey thau plays and explained that he is likely assisting.The patient¿s race is black, non-hispanic, weight 177 pounds.Reportedly, the patient left the procedure feeling fine.They returned 4 to 15 days later with an infection.Their visual acuity prior to the implantation was 20/50 -2 taken on (b)(6) 2023.Visual acuity after the implantation was 20/30+2 taken on (b)(6) 2023.On (b)(6) 2023, they were still experiencing blurry vision, visual acuity 20/40+2.Patient complained of irritation and discomfort however that has resolved.They report constant blurriness in their right eye.The results of their eye culture showed cutibacterium acnes.They have three cases of eye infections with the jnj iol but to date only this case resulted in cutibacterium acnes.They have labeled this case as endophthalmitis.Patient was additionally prescribed prednisolone moxyfloxacine, intravitreal injection (ivi) steroid, atropine, and cyclogyl.The only pattern they¿ve noticed is that all three patients have a jnj lens.The customer is looking into what they re-use and converting to single use only.For example, their cannulas are reusable.The customer was asked if they used jnj ophthalmic viscosurgical device (ovd) for these cases however, they were not able to confirm.In abundance of caution, they were reminded that jnj¿s ovds are not designed or intended to be attached to instruments other than the one provided with the product.Additionally, the product and cannula are for single use only.Re-use may cause eye inflammation.The customer said they are trying to investigate all avenues.No further information was provided.The following sections have been updated with the new information.Section a4, patient weight: 177 pounds.Section a5,ethnicity: not hispanic/latino.Section a5, race: black or african american.Section h6, health effect ¿ clinical code: 4803 captures eye irritation.1835 captures the endophthalmitis.2137 captures blurred vision.4467 captures ocular discomfort.Corrected data.Section e1, initial reporter first/given name: (b)(6).Section e1, initial reporter middle name: (b)(6).Section e1, initial reporter last name: (b)(6).Section e1, initial reporter email address: (b)(6).Section e1, initial reporter establishment name: (b)(6).Section e1, initial reporter address ¿ line 1: (b)(6).Section e1, initial reporter telephone number: (b)(6).All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|